The Impact Assessment study on fragrance labelling on cosmetic products (575/PP/2016/FC) has been commissioned by the European Commission in 2019 with the objective to provide input for a possible new initiative following the 26-27 June 2012 Opinion of the Scientific Committee on...
In March 2019, the Commission adopted the European Union Strategic Approach to Pharmaceuticals in the Environment (PiE) which focuses on actions to address the environmental implications of all phases of the lifecycle of (both human and veterinary) pharmaceuticals, from design an...
The European Commission published a public consultation on the Pharmaceutical Strategy - Timely Patient Access to Affordable Medicines, which was available for stakeholders to comment on and share their views from 16 June 2020 to 15 September 2020. This report presents a neutral,...
In recent years, due to the expansion of China’s middle class, increased interest in personal care has led to the rapid development of the cosmetics industry. In addition, the adjustment of the tariff system in China and the rise of e-commerce platforms such as Taobao, Jingdong a...
The pharmaceuticals and biotechnology sector is characterised by massive consolidation, from 60 firms in 1995, 10 global pharma companies emerged by 2015 through a series of mergers and acquisitions (M&As). This move has been partly driven by declining R&D productivity an...
This report, one in a series of studies by the OECD and the European Union Intellectual Property Office (EUIPO), is designed to enhance understanding of the issues and challenges facing governments, businesses and society posed by the trade in fake pharmaceutical products. Illici...
The current drug development paradigm is too drug-centred and does not sufficiently take account of the patients that will receive the new therapy. This has led to the emergence of a research gap between the pre-approval development of medicines and their post-approval use in rea...
1. In light of the data provided, does the SCCS consider Hydroxypropyl p-phenylenediamine and its dihydrochloride salt (A165), safe when used in oxidative hair colouring products up to a maximum on-head concentration of 2 %? In light of the data provided, the SCCS considers that ...
1. In light of the data provided, does the SCCS consider 1,2,4-trihydroxybenzene (1,2,4-THB) (A33) safe for use as an auto-oxidative hair dye in permanent hair dye formulations, not requiring the action of peroxide, with a maximum on-head concentration of 2.5%? On the basis of al...
